In oral cancer, STAT2 is associated with activated T-Cell signature and better outcome.[7] Moreover, high expression of STAT2 predicted poor prognosis in non-small cell lung cancer.[8] STAT2 acted as a prognostic biomarker in colorectal cancer.[9]. This evidence concerns the gene STAT2 and non-small cell lung carcinoma.